On Holding tops estimates as premium strategy pays off; Hims & Hers posts surprise loss, shares slide
On Holding beat Wall Street with $1.07B revenue and $0.40 adjusted EPS for Q1 2026, and lifted profitability targets to at least 64.5% gross margin and 19.5–20% EBITDA margin for 2026. In contrast, Hims & Hers Health swung to a Q1 net loss of $92.1M (−$0.40 per share) on $608M revenue, missing estimates, as it pivots to branded GLP-1 products and partners with Novo Nordisk; the stock fell about 8% after hours amid the weaker results.